V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001620 | 230008019 | null | null | null | null | 2020-04-21 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100388675 |
| 230001625 | 230008020 | 1.57 | 80.6 | null | 2020-09-29 | 2021-05-12 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100189085 |
| 230001629 | 230008022 | null | null | null | 2020-11-06 | 2020-11-08 | null | null | null | CISPLATIN | 101446426 |
| 230001632 | 230008023 | 1.6 | 85 | null | null | 2019-04-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100133467 |
| 230001637 | 230008026 | 1.67 | 65.15 | null | null | 2021-04-28 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100512559 |
| 230001638 | 230008027 | null | null | Palliative (P) | null | 2021-02-05 | null | 02 | N | IPILIMUMAB + NIVOLUMAB | 101616533 |
| 230001639 | 230008028 | null | null | Palliative (P) | 2020-01-16 | 2020-04-08 | null | null | N | CISPLATIN | 101709115 |
| 230001642 | 230008029 | 1.62 | 87 | null | null | 2022-03-23 | null | 02 | null | PEMBROLIZUMAB | 101056528 |
| 230001650 | 230008033 | 1.53 | 110.6 | Palliative (P) | null | 2019-01-30 | Olaparib | 02 | N | OLAPARIB | 100887276 |
| 230001653 | 230008034 | 1.57 | 81 | null | null | 2019-01-04 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101812817 |
| 230001654 | 230008035 | 1.66 | 117.7 | null | 2021-02-05 | 2021-03-08 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100223869 |
| 230001657 | 230008036 | 1.45 | 97.6 | null | 2021-08-27 | 2021-08-28 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101223342 |
| 230001662 | 230008037 | 1.65 | 53.9 | null | 2017-02-15 | 2017-02-15 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 100739333 |
| 230001664 | 230008038 | null | null | null | null | 2016-11-09 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 101114908 |
| 230001668 | 230008040 | 1.76 | 63.9 | null | 2020-10-10 | 2020-10-10 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101809469 |
| 230001669 | 230008041 | 1.6 | 74 | null | null | 2019-04-05 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 100283578 |
| 230001676 | 230008044 | null | null | null | null | 2018-04-27 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101425965 |
| 230001680 | 230008046 | 1.61 | 71.3 | Palliative (P) | 2021-05-04 | 2021-05-11 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101385244 |
| 230001687 | 230008048 | 1.57 | 59.4 | null | 2021-03-20 | 2021-07-03 | null | null | null | LIPOSOMAL DOXORUBICIN | 101774313 |
| 230001689 | 230008050 | null | null | null | null | 2020-02-24 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101682187 |
| 230001690 | 230008051 | null | null | Neo-adjuvant (N) | 2019-05-13 | 2019-06-11 | null | 02 | null | FLUOROURACIL + OXALIPLATIN | 100021121 |
| 230001691 | 230008052 | 1.71 | 72 | Neo-adjuvant (N) | null | 2019-08-09 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101268722 |
| 230001696 | 230008053 | 1.6 | 55 | Palliative (P) | 2021-10-05 | 2021-12-05 | null | null | N | BEVACIZUMAB | 100908625 |
| 230001697 | 230008054 | 1.66 | 52.4 | null | 2018-07-07 | 2018-07-16 | CARBOPLATIN | N | null | PEMBROLIZUMAB | 100546781 |
| 230001698 | 230008055 | 1.62 | 123.7 | null | 2020-01-08 | 2020-01-15 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101756307 |
| 230001700 | 230008056 | 1.59 | 57.8 | Palliative (P) | 2020-12-14 | 2020-12-16 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100839093 |
| 230001704 | 230008058 | 1.66 | 63.5 | null | 2020-12-19 | 2020-12-26 | null | null | null | BEVACIZUMAB | 100477714 |
| 230001713 | 230008061 | null | null | null | 2019-07-31 | 2019-08-13 | ICON8B TRIAL | null | null | CARBOPLATIN | 100860635 |
| 230001715 | 230008062 | 1.54 | 59.2 | Curative (C) | 2019-03-25 | 2019-04-05 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100533828 |
| 230001716 | 230008063 | 1.6 | 62 | 03 | 2020-03-11 | 2020-04-26 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100797083 |
| 230001720 | 230008066 | null | null | null | null | 2021-12-16 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100401581 |
| 230001723 | 230008067 | 1.65 | 53.9 | null | 2021-08-11 | 2021-11-11 | null | 02 | null | PEMBROLIZUMAB | 101704693 |
| 230001724 | 230008068 | null | null | null | null | 2020-11-11 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100587386 |
| 230001728 | 230008069 | 1.66 | 43.9 | null | 2019-10-22 | 2019-11-05 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100063430 |
| 230001729 | 230008070 | 1.53 | 55.9 | null | 2021-05-01 | 2021-05-16 | Bevacizumab | 02 | null | BEVACIZUMAB | 100752053 |
| 230001733 | 230008072 | null | null | null | 2017-04-08 | 2018-12-25 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100913514 |
| 230001737 | 230008074 | 1.62 | 74 | Palliative (P) | 2020-02-18 | 2020-03-10 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101092550 |
| 230001741 | 230008076 | 1.62 | 83.3 | Palliative (P) | null | 2019-06-10 | Olaparib | 02 | null | OLAPARIB | 100943715 |
| 230001742 | 230008077 | 1.53 | 102.2 | null | 2016-08-16 | 2016-08-19 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100341122 |
| 230001745 | 230008079 | 1.62 | 67.9 | null | 2022-04-05 | 2022-04-06 | null | 02 | null | IPILIMUMAB + NIVOLUMAB | 101315132 |
| 230001749 | 230008081 | 1.54 | 67.8 | null | 2020-10-18 | 2020-10-18 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100466822 |
| 230001751 | 230008082 | 1.71 | 57.7 | null | 2019-01-23 | 2019-12-08 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101665032 |
| 230001754 | 230008083 | null | null | null | 2019-11-15 | 2019-12-09 | null | null | null | CISPLATIN + GEMCITABINE | 101336225 |
| 230001758 | 230008087 | 1.52 | 41.1 | null | 2020-01-18 | 2021-09-07 | null | 99 | null | CISPLATIN | 100637812 |
| 230001762 | 230008088 | null | null | null | 2011-09-20 | 2016-07-27 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101493624 |
| 230001764 | 230008089 | null | null | null | null | 2018-12-28 | PACLITAXEL | 02 | null | PACLITAXEL | 101340797 |
| 230001765 | 230008090 | 1.59 | 85 | null | 2020-12-08 | 2021-01-20 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101085764 |
| 230001766 | 230008091 | 1.64 | 60.9 | Palliative (P) | null | 2018-05-18 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100506918 |
| 230001768 | 230008093 | null | null | null | 2019-08-07 | 2019-08-07 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101335236 |
| 230001770 | 230008094 | 1.54 | 73.6 | null | 2019-10-03 | 2020-01-31 | null | null | null | ICON8B TRIAL | 100978318 |